glp-3 rt vs retatrutide 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 New Phase 3 clinical results are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of cardiovascular support Size:6 x 10mg/10mg/600mg News from the FDA

glp-3 rt vs retatrutide 💊🔥 Retatrutide: The Most Powerful Weight-Loss Drug Yet? 🧬📊 New Phase 3 clinical results are turning heads retatrutide, a next-generation triple-agonist targeting GLP-1, GIP and glucagon receptors, is showing unmatched levels of cardiovascular support Size:6 x 10mg/10mg/600mg News from the FDA

News from the FDA today!! Zepbound (Tirzepatide) is a GLP-1 Agonist that has been approved for weight loss in obese patients (BMI >30) and overweight patients (BMI >27) with at least one ...

Track for one week, then adjust

cardiovascular support

Size:6 x 10mg/10mg/600mg

But Lilly won’t be alone in these uncharted waters for much longer—in August, Pfizer announced its plan to enter the DTC market with the “PfizerForAll” web platform